Key result
Multimodal deep learning model predicts elevated NT-proBNP with ~0.90 AUROC from ECG and clinical data.
Why the study?
The study investigated the feasibility of using ECG data combined with basic patient metadata to estimate and monitor prompt laboratory abnormalities.
Does a multimodal deep learning model using ECG and clinical data accurately predict and forecast laboratory abnormalities in ICU/ED patients?
Observational (n=127,994)
No
Does a multimodal deep learning model using ECG and clinical data accurately predict and forecast laboratory abnormalities in ICU/ED patients?
Effect estimate: AUROC 0.903 (95% CI 0.883-0.923)
Multimodal deep learning combining ECG and clinical data can accurately predict and forecast critical laboratory abnormalities, offering a non-invasive monitoring tool.
Hypothesis-generating for multimodal ECG-clinical prediction of lab abnormalities in acute care; prospective validation required before adoption.
This study investigates the feasibility of using electrocardiogram (ECG) data combined with basic patient metadata to estimate and monitor prompt laboratory abnormalities. We use the MIMIC-IV dataset to train multimodal deep learning models on ECG waveforms, demographics, biometrics, and vital signs. Our model is a structured state space classifier with late fusion for metadata. We frame the task as individual binary classifications per abnormality and evaluate performance using AUROC. The models achieve strong performance, with AUROCs above 0.70 for 24 lab values in abnormality prediction and up to 24 in abnormality forecasting, across cardiac, renal, hematological, metabolic, immunological, and coagulation categories. NTproBNP (≥ 353 pg/mL) is best predicted (AUROC > 0.90). Other values with AUROC > 0.85 include Hemoglobin (≥ 17.5 g/dL), Albumin (≥ 5.2 g/dL), and Hematocrit (≥ 51%). Our findings show ECG combined with clinical data enables prompt abnormality prediction and forecasting of lab abnormalities, offering a non-invasive, cost-effective alternative to traditional testing. This can support early intervention and enhanced patient monitoring. ECG and clinical data can help estimate and monitor abnormal lab values, potentially improving care while reducing reliance on invasive and costly procedures.
No takes yet. Share an insight, caveat, or question.
Alcaraz et al. (2025) conducted an observational in ICU and ED patients requiring laboratory testing and ECG monitoring (n=127,994). Multimodal deep learning model (ECG and clinical metadata) was evaluated on Prediction of elevated NTproBNP (≥ 353 pg/mL) (AUROC 0.903, 95% CI 0.883-0.923). A multimodal deep learning model combining ECG waveforms and clinical data accurately predicted laboratory abnormalities, achieving an AUROC of 0.903 for elevated NTproBNP and AUROCs >0.70 for 24 lab values.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: